Hydrochlorothiazide
- Product NDC
- 50228-112
- 11-digit product format
- 502280112
- Labeler code
- 50228
- Product ID
- 50228-112_5c6f4c6a-cc43-4f4d-bc16-688310c98c72
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Application
- ANDA203018
- Marketing category
- ANDA
- Marketing start
- 2014-02-05
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydrochlorothiazide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HYDROCHLOROTHIAZIDE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0J48LPH2TH |
| Rxcui | 197770, 310798 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50228-112-10 | Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | | 4 |
| 50228-112-30 | Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
| STARCH, PREGELATINIZED CORN | INACTIVE INGREDIENT | O8232NY3SJ | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50228-112 | HYDROCHLOROTHIAZIDE TABLET [SCIEGEN PHARMACEUTICALS, INC.] | 4 | Current NDC, Legacy NDC, 2 package rows | 20200613_02e96a51-1d56-460c-8c20-3d6f37e0ce46.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50228-112-10 | 50228011210 | 1000 TABLET in 1 BOTTLE (50228-112-10) | 1000 tablet | 2014-02-05 | 0000-00-00 | No | No | Current |
| 50228-112-30 | 50228011230 | 30 TABLET in 1 BOTTLE (50228-112-30) | 30 tablet | 2014-02-05 | 0000-00-00 | No | No | Current |